Publication | Closed Access

Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine

VaccinationImmunodominant EpitopesAllergyVivo EvaluationVaccine TargetImmunologyImmunodominanceTherapeutic VaccineAutoimmunityImmunotherapeuticsVaccine DesignPolyvalent VaccineImmunotherapyMedicineProphylactic Melanoma Vaccine